Short Interest in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Rises By 315.4%

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) was the recipient of a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 96,526 shares, a growth of 315.4% from the June 15th total of 23,236 shares. Based on an average daily trading volume, of 40,529 shares, the days-to-cover ratio is presently 2.4 days. Currently, 3.3% of the shares of the company are short sold.

ALPS Medical Breakthroughs ETF Stock Down 2.5%

Shares of SBIO stock traded down $1.72 on Friday, hitting $67.22. 61,817 shares of the stock traded hands, compared to its average volume of 37,322. The firm has a 50 day simple moving average of $56.61 and a two-hundred day simple moving average of $53.51. ALPS Medical Breakthroughs ETF has a 52 week low of $32.21 and a 52 week high of $69.34.

Hedge Funds Weigh In On ALPS Medical Breakthroughs ETF

Institutional investors have recently bought and sold shares of the business. Delta Investment Management LLC bought a new stake in shares of ALPS Medical Breakthroughs ETF in the 4th quarter valued at approximately $6,112,000. Bank of America Corp DE lifted its stake in shares of ALPS Medical Breakthroughs ETF by 63.1% during the 1st quarter. Bank of America Corp DE now owns 98,679 shares of the company’s stock worth $5,165,000 after purchasing an additional 38,193 shares during the last quarter. LPL Financial LLC boosted its holdings in shares of ALPS Medical Breakthroughs ETF by 438.7% in the 4th quarter. LPL Financial LLC now owns 42,755 shares of the company’s stock valued at $2,190,000 after buying an additional 34,819 shares in the last quarter. Griffin Asset Management Inc. boosted its stake in ALPS Medical Breakthroughs ETF by 1.9% in the fourth quarter. Griffin Asset Management Inc. now owns 30,699 shares of the company’s stock valued at $1,572,000 after acquiring an additional 564 shares in the last quarter. Finally, Moran Wealth Management LLC grew its stake in ALPS Medical Breakthroughs ETF by 39.2% during the 1st quarter. Moran Wealth Management LLC now owns 29,348 shares of the company’s stock worth $1,536,000 after buying an additional 8,264 shares during the last quarter.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.